Manchester Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.58K | Buy |
166
+64
| +63% | +$1.77K | ﹤0.01% | 916 |
|
|
2025
Q1 | $2.89K | Buy |
102
+33
| +48% | +$936 | ﹤0.01% | 966 |
|
|
2024
Q4 | $2.87K | Sell |
69
-7
| -9% | -$291 | ﹤0.01% | 962 |
|
|
2024
Q3 | $5.08K | Sell |
76
-118
| -61% | -$7.89K | ﹤0.01% | 885 |
|
|
2024
Q2 | $23K | Buy |
194
+82
| +73% | +$9.74K | ﹤0.01% | 639 |
|
|
2024
Q1 | $11.9K | Sell |
112
-152
| -58% | -$16.2K | ﹤0.01% | 613 |
|
|
2023
Q4 | $26.3K | Buy |
264
+34
| +15% | +$3.38K | ﹤0.01% | 497 |
|
|
2023
Q3 | $23.8K | Buy |
230
+162
| +238% | +$16.7K | ﹤0.01% | 507 |
|
|
2023
Q2 | $8.26K | Hold |
68
| – | – | ﹤0.01% | 560 |
|
|
2023
Q1 | $10.4K | Hold |
68
| – | – | ﹤0.01% | 536 |
|
|
2022
Q4 | $12.2K | Hold |
68
| – | – | ﹤0.01% | 446 |
|
|
2022
Q3 | $8K | Hold |
68
| – | – | ﹤0.01% | 468 |
|
|
2022
Q2 | $10K | Hold |
68
| – | – | ﹤0.01% | 488 |
|
|
2022
Q1 | $12K | Sell |
68
-373
| -85% | -$65.8K | ﹤0.01% | 518 |
|
|
2021
Q4 | $112K | Buy |
441
+124
| +39% | +$31.5K | 0.01% | 328 |
|
|
2021
Q3 | $122K | Buy |
317
+249
| +366% | +$95.8K | 0.02% | 336 |
|
|
2021
Q2 | $16K | Hold |
68
| – | – | ﹤0.01% | 460 |
|
|
2021
Q1 | $9K | Buy |
68
+59
| +656% | +$7.81K | ﹤0.01% | 489 |
|
|
2020
Q4 | $1K | Buy |
9
+4
| +80% | +$444 | ﹤0.01% | 665 |
|
|
2020
Q3 | $0 | Sell |
5
-2,638
| -100% | – | ﹤0.01% | 636 |
|
|
2020
Q2 | $170K | Buy |
2,643
+927
| +54% | +$59.6K | 0.02% | 245 |
|
|
2020
Q1 | $51K | Buy |
+1,716
| New | +$51K | 0.01% | 348 |
|